Dissociation of c-Met phosphotyrosine sites in human cells in response to mouse hepatocyte growth factor but not human hepatocyte growth factor: The possible roles of different amino acids in different species

Cell Biochemistry and Function

Volumn 31, Issue 4, 2013, Pages 298-304

  Ikebuchi, Fumie ^a,b   Oka, Kiyomasa ^a   Mizuno, Shinya ^c   Fukuta, Kazuhiro ^b   Hayata, Daichika ^a,b   Ohnishi, Hiroyuki ^a   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Saito Laboratory   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Amino acid sequence; C Met; HGF; Multidocking site; Tyrosine phosphorylation

Indexed keywords

AMINO ACID; ARGININE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TYROSINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL MIGRATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; DOGS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HUMANS; KINETICS; MICE; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-MYC; SPECIES SPECIFICITY;

EID: 84878730872     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.2898     Document Type: Article

References (33)

1. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459.
2. Russell WE, McGowan JA, Bucher NL. Partial characterization of a hepatocyte growth factor from rat platelets. J Cell Physiol 1984; 119: 183-192.
3. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443.
4. Miyazawa K, Tsubouchi H, Naka D, et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-973.
5. Bottaro DP, Rubin JS, Faletto DL, et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 125: 802-804.
6. Higuchi O, Mizuno K, Vande Woude G, Nakamura T. Expression of c-met proto-oncogene in COS cells induces the signal transducing high-affinity receptor for hepatocyte growth factor. FEBS Lett 1992; 301: 282-286.
7. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404-410.
8. Nakamura T, Mizuno S. The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc Jpn Acad Ser B 2010; 86: 588-610.
9. Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet 1995; 345: 293-295.
10. Gong R. Multi-target anti-inflammatory action of hepatocyte growth factor. Curr Opin Investig Drugs 2008; 9: 1163-1170.
11. Matsumoto K, Nakamura T. NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics. Cancer Sci 2003; 94: 321-327.
12. Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11: 834-848.
13. Gherardi E, Sandin S, Petoukhov MV, et al. Structural basis of hepatocyte growth factor/scatter factor and MET signaling. Proc Natl Acad Sci USA 2006; 103: 4046-4051.
14. Basilico C, Arnesano A, Galluzzo M, Comoglio PM, Michieli P. A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met. J Biol Chem 2008; 283: 21267-21277.
15. Ponzetto C, Bardelli A, Zhen Z, et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 1994; 77: 261-271.
16. Mizuno K, Inoue H, Hagiya M, et al. Hairpin loop and second kringle domain are essential sites for heparin binding and biological activity of hepatocyte growth factor. J Biol Chem 1994; 269: 1131-1136.
17. Lokker NA, Presta LG, Godowski PJ. Mutational analysis and molecular modeling of the N-terminal kringle-containing domain of hepatocyte growth factor identifies amino acid side chains important for interaction with the c-Met receptor. Protein Eng 1994; 7: 895-903.
18. Matsumoto K, Kataoka H, Date K, Nakamura T. Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses. J Biol Chem 1998; 273: 22913-22920.
19. Fukuta K, Matsumoto K, Nakamura T. Multiple biological responses are induced by glycosylation-deficient hepatocyte growth factor. Biochem J 2005; 388: 555-562.
20. Tashiro K, Hagiya M, Nishizawa T, et al. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Natl Acad Sci USA 1990; 87: 3200-3204.
21. Kirchhofer D, Yao X, Peek M, et al. Structural and functional basis of the serine protease-like hapatocyte growth factor β-chain in Met binding and signaling. J Biol Chem 2004; 279: 39915-39924.
22. Hashigasako A, Machide M, Nakamura T, Matsumoto K, Nakamura T. Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor. J Biol Chem 2004; 279: 26445-26452.
23. Machide M, Hashigasako A, Matsumoto K, Nakamura T. Contact inhibition of hepatocyte growth regulated by functional association of the c-Met/hepatocyte growth factor receptor and LAR protein-tyrosine phosphatase. J Biol Chem 2006; 281: 8765-8772.
24. Lee HS, Huang GT, Sheu JC, et al. Lack of critical domains in the beta-chain of hepatocyte growth factor. Biochem Biophys Res Commun 1995; 210: 1017-1024.
25. Kinosaki M, Yamaguchi K, Murakami A, Morinaga T, Ueda M, Higashio K. Analysis of deleted variant of hepatocyte growth factor by alanine scanning mutagenesis: identification of residues essential for its biological function and generation of mutants with enhanced mitogenic activity on rat hepatocytes. FEBS Lett 1998; 434: 165-170.
26. Hartmann G, Prospero T, Brinkmann V, et al. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr Biol 1998; 8: 125-134.
27. Tolbert WD, Daugherty-Holtrop J, Gherardi E, Vande Woude G, Xu HE. Structural basis for agonism and antagonism of hepatocyte growth factor. Proc Natl Acad Sci USA 2010; 107: 13264-13269.
28. Lietha D, Chirgadze DY, Mulloy B, Blundell TL, Gherardi E. Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J 2001; 20: 5543-5555.
29. Ross J, Gherardi E, Mallorqui-Fernandez N, et al. Protein engineered variants of hepatocyte growth factor/scatter factor promote proliferation of primary human hepatocytes and in rodent liver. Gastroenterology 2012; 142: 897-906.
30. Kirchhofer D, Lipari MT, Santell L, et al. Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist. Proc Natl Acad Sci USA 2007; 104: 5306-5311.
31. Stamos J, Lazarus RA, Yao X, Kirchhofer D, Wiesmann C. Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor. EMBO J 2004; 23: 2325-2335.
32. Donate LE, Gherardi E, Srinivasan N, Sowdhamini R, Aparicio S, Blundell TL. Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci 1994; 3: 2378-2394.
33. Miyata Y, Kanetake H, Kanda S. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumour progression and survival in patients with conventional renal cell carcinoma. Clin Cancer Res 2006; 12: 4876-4881.